@article{AyBrysonWeckHeinzeetal.2020, author = {Ay-Bryson, Destina Sevde and Weck, Florian and Heinze, Peter Eric and Lang, Thomas and K{\"u}hne, Franziska}, title = {Can psychotherapy trainees distinguish standardized patients from real patients?}, series = {Zeitschrift f{\"u}r Klinische Psychologie und Psychotherapie}, volume = {49}, journal = {Zeitschrift f{\"u}r Klinische Psychologie und Psychotherapie}, number = {3}, publisher = {Hogrefe}, address = {G{\"o}ttingen}, issn = {1616-3443}, doi = {10.1026/1616-3443/a000594}, pages = {182 -- 190}, year = {2020}, abstract = {Background: Under the new psychotherapy law in Germany, standardized patients (SPs) are to become a standard component inpsychotherapy training, even though little is known about their authenticity.Objective:The present pilot study explored whether, followingan exhaustive two-day SP training, psychotherapy trainees can distinguish SPs from real patients. Methods: Twenty-eight psychotherapytrainees (M= 28.54 years of age,SD= 3.19) participated as blind raters. They evaluated six video-recorded therapy segments of trained SPsand real patients using the Authenticity of Patient Demonstrations Scale. Results: The authenticity scores of real patients and SPs did notdiffer (p= .43). The descriptive results indicated that the highest score of authenticity was given to an SP. Further, the real patients did notdiffer significantly from the SPs concerning perceived impairment (p= .33) and the likelihood of being a real patient (p= .52). Conclusions: The current results suggest that psychotherapy trainees were unable to distinguish the SPs from real patients. We therefore stronglyrecommend incorporating training SPs before application. Limitations and future research directions are discussed.}, language = {en} } @article{KoshkinaLangThiermannetal.2015, author = {Koshkina, Olga and Lang, Thomas and Thiermann, Raphael and Docter, Dominic and Stauber, Roland H. and Secker, Christian and Schlaad, Helmut and Weidner, Steffen and Mohr, Benjamin and Maskos, Michael and Bertin, Annabelle}, title = {Temperature-Triggered Protein Adsorption on Polymer-Coated Nanoparticles in Serum}, series = {Langmuir}, volume = {31}, journal = {Langmuir}, number = {32}, publisher = {American Chemical Society}, address = {Washington}, issn = {0743-7463}, doi = {10.1021/acs.langmuir.5b00537}, pages = {8873 -- 8881}, year = {2015}, abstract = {The protein corona, which forms on the nanoparticle's surface in most biological media, determines the nanoparticle's physicochemical characteristics. The formation of the protein corona has a significant impact on the biodistribution and clearance of nanoparticles in vivo. Therefore, the ability to influence the formation of the protein corona is essential to most biomedical applications, including drug delivery and imaging. In this study, we investigate the protein adsorption on nanoparticles with a hydrodynamic radius of 30 nm and a coating of thermoresponsive poly(2-isopropyl-2-oxazoline) in serum. Using multiangle dynamic light scattering (DLS) we demonstrate that heating of the nanoparticles above their phase separation temperature induces the formation of agglomerates, with a hydrodynamic radius of 1 mu m. In serum, noticeably stronger agglomeration occurs at lower temperatures compared to serum-free conditions. Cryogenic transmission electron microscopy (cryo-TEM) revealed a high packing density of agglomerates when serum was not present. In contrast, in the presence of serum, agglomerated nanoparticles were loosely packed, indicating that proteins are intercalated between them. Moreover, an increase in protein content is observed upon heating, confirming that protein adsorption is induced by the alteration of the surface during phase separation. After cooling and switching the surface back, most of the agglomerates were dissolved and the main fraction returned to the original size of approximately 30 nm as shown by asymmetrical flow-field flow fractionation (AF-FFF) and DLS. Furthermore, the amounts of adsorbed proteins are similar before and after heating the nanoparticles to above their phase-separation temperature. Overall, our results demonstrate that the thermoresponsivity of the polymer coating enables turning the corona formation on nanoparticles on and off in situ. As the local heating of body areas can be easily done in vivo, the thermoresponsive coating could potentially be used to induce the agglomeration of nanopartides and proteins and the accumulation of nanoparticles in a targeted body region.}, language = {en} } @article{MaiwaldJungaLangetal.2019, author = {Maiwald, Lisa Marie and Junga, Yvonne Marie and Lang, Thomas and Montini, Romina and Witth{\"o}ft, Michael and Heider, Jens and Schr{\"o}der, Annette and Weck, Florian}, title = {The role of therapist and patient in-session behavior for treatment outcome in exposure-based cognitive behavioral therapy for panic disorder with agoraphobia}, series = {Journal of clinical psychology}, volume = {75}, journal = {Journal of clinical psychology}, number = {4}, publisher = {Wiley}, address = {Hoboken}, issn = {0021-9762}, doi = {10.1002/jclp.22738}, pages = {614 -- 626}, year = {2019}, abstract = {Objective There is a very limited amount of research on the relationship between therapist and patient in-session behavior and treatment outcome in cognitive behavioral therapy (CBT) for panic disorder with agoraphobia (PD/AG). Additionally, the findings tend to be inconclusive. This study investigates the association between therapist competence, adherence, patient interpersonal behavior, and therapeutic alliance and outcome in a low-control CBT setting by using comprehensive measures. Methods Twenty-six patients with PD/AG received 12 sessions of exposure-based CBT. With regard to the outcome, treatments were classified either as problematic or nonproblematic by means of distinct criteria. Two raters evaluated the in-session behavior. Results Patient interpersonal behavior was significantly associated with outcome at follow-up (r = 0.49). At posttreatment, the correlation did not reach significance ( r = 0.34). Competence, adherence, and alliance were not outcome associated. Conclusion The findings emphasize the need for therapists to pay particular attention to patients' interpersonal behavior during treatment.}, language = {en} } @article{WeckGrikscheitHoeflingetal.2016, author = {Weck, Florian and Grikscheit, Florian and H{\"o}fling, Volkmar and Kordt, Anne and Hamm, Alfons O. and Gerlach, Alexander L. and Alpers, Georg W. and Arolt, Volker and Kircher, Tilo and Pauli, Paul and Rief, Winfried and Lang, Thomas}, title = {The role of treatment delivery factors in exposure-based cognitive behavioral therapy for panic disorder with agoraphobia}, series = {Journal of anxiety disorders}, volume = {42}, journal = {Journal of anxiety disorders}, publisher = {Elsevier}, address = {Oxford}, issn = {0887-6185}, doi = {10.1016/j.janxdis.2016.05.007}, pages = {10 -- 18}, year = {2016}, abstract = {Treatment delivery factors (i.e., therapist adherence, therapist competence, and therapeutic alliance) are considered to be important for cognitive behavioral therapy (CBT) for panic disorder and agoraphobia (PD/AG). In the current study, four independent raters conducted process evaluations based on 168 two-hour videotapes of 84 patients with PD/AG treated with exposure-based CBT. Two raters evaluated patients' interpersonal behavior in Session 1. Two raters evaluated treatment delivery factors in Session 6, in which therapists provided the rationale for conducting exposure exercises. At the 6-month follow-up, therapists' adherence (r = 0.54) and therapeutic alliance (r = 0.31) were significant predictors of changes in agoraphobic avoidance behavior; therapist competence was not associated with treatment outcomes. Patients' interpersonal behavior in Session 1 was a significant predictor of the therapeutic alliance in Session 6 (r = 0.17). The findings demonstrate that treatment delivery factors, particularly therapist adherence, are relevant to the long-term success of CBT for PD/AG.}, language = {en} } @article{KoshkinaWestmeierLangetal.2016, author = {Koshkina, Olga and Westmeier, Dana and Lang, Thomas and Bantz, Christoph and Hahlbrock, Angelina and W{\"u}rth, Christian and Resch-Genger, Ute and Braun, Ulrike and Thiermann, Raphael and Weise, Christoph and Eravci, Murat and Mohr, Benjamin and Schlaad, Helmut and Stauber, Roland H. and Docter, Dominic and Bertin, Annabelle and Maskos, Michael}, title = {Tuning the Surface of Nanoparticles: Impact of Poly(2-ethyl-2-oxazoline) on Protein Adsorption in Serum and Cellular Uptake}, series = {Macromolecular bioscience}, volume = {16}, journal = {Macromolecular bioscience}, publisher = {Wiley-VCH}, address = {Weinheim}, issn = {1616-5187}, doi = {10.1002/mabi.201600074}, pages = {1287 -- 1300}, year = {2016}, abstract = {Due to the adsorption of biomolecules, the control of the biodistribution of nanoparticles is still one of the major challenges of nanomedicine. Poly(2-ethyl-2-oxazoline) (PEtOx) for surface modification of nanoparticles is applied and both protein adsorption and cellular uptake of PEtOxylated nanoparticles versus nanoparticles coated with poly(ethylene glycol) (PEG) and non-coated positively and negatively charged nanoparticles are compared. Therefore, fluorescent poly(organosiloxane) nanoparticles of 15 nm radius are synthesized, which are used as a scaffold for surface modification in a grafting onto approach. With multi-angle dynamic light scattering, asymmetrical flow field-flow fractionation, gel electrophoresis, and liquid chromatography-mass spectrometry, it is demonstrated that protein adsorption on PEtOxylated nanoparticles is extremely low, similar as on PEGylated nanoparticles. Moreover, quantitative microscopy reveals that PEtOxylation significantly reduces the non-specific cellular uptake, particularly by macrophage-like cells. Collectively, studies demonstrate that PEtOx is a very effective alternative to PEG for stealth modification of the surface of nanoparticles.}, language = {en} }